J Eur Acad Dermatol Venereol 2004;18(6):676-678
While theres no direct evidence that IGF-1 causes cancer, it can theoretically accelerate the growth of existing or dormant tumors , especially in hormone-sensitive tissues like the breast, prostate, or colon
Expected Results and Timeline Results from glutathione supplementation vary based on individual factors such as skin type, lifestyle, dosage, and baseline glutathione levels
The peptides may have potential roles as adjunctive therapies or alternative treatments for patients who cannot tolerate or do not respond adequately to conventional treatments, but this should be based on careful risk-benefit analysis and appropriate patient selection
Written by Garret Grant Founder & Lead Researcher B.S
The 10 mg dose falls within the studied range